An augmented ABCA4 screen targeting noncoding regions reveals a deep intronic founder variant in Belgian Stargardt patients

Hum Mutat. 2015 Jan;36(1):39-42. doi: 10.1002/humu.22716.


Autosomal-recessive Stargardt disease (STGD1) is hallmarked by a large proportion of patients with a single heterozygous causative variant in the disease gene ABCA4. Braun et al. () reported deep intronic variants of ABCA4 in STGD1 patients with one coding variant, prompting us to perform an augmented screen in 131 Belgian STGD1 patients with one or no ABCA4 variant to uncover deep intronic causal ABCA4 variants. This revealed a second variant in 28.6% of cases. Twenty-six percent of these carry the same causal variant c.4539+2001G>A (V4). Haplotyping in V4 carriers showed a common region of 63 kb, suggestive of a founder mutation. Genotype-phenotype correlations suggest a moderate-to-severe impact of V4 on the STGD1 phenotype. In conclusion, V4 occurs in a high fraction of Belgian STGD1 patients and represents the first deep intronic founder mutation in ABCA4. This emphasizes the importance of augmented molecular genetic testing of ABCA4 in Belgian STGD1.

Keywords: ABCA4; STGD1; Stargardt; deep intronic mutation; founder; genotype-phenotype correlations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP-Binding Cassette Transporters / genetics*
  • Belgium
  • Founder Effect*
  • Genetic Association Studies
  • Haplotypes
  • Humans
  • Introns
  • Macular Degeneration / congenital*
  • Macular Degeneration / genetics
  • Mutation
  • Stargardt Disease


  • ABCA4 protein, human
  • ATP-Binding Cassette Transporters